S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Central Bank: “Final stage” beginning now (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Central Bank: “Final stage” beginning now (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Central Bank: “Final stage” beginning now (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
This MMJ Stock Needs To Be At The Top Of Your Radar! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Central Bank: “Final stage” beginning now (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain

Best Stocks Under $30.00 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $30.00 (30 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.


JD Sports Fashion stock logo

#1 - JD Sports Fashion

OTCMKTS:JDSPY
Stock Price: $2.39 (+$0.04)
Average Trading Volume: 2,469 shares
Consensus Rating: Strong Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $203.33 (8,407.7% Upside)
JD Sports Fashion Plc retails and distributes sports fashion wear and outdoor clothing and equipment. It operates through the Sports Fashion and Outdoor segments. The Sports Fashion segment consists of JD Sports Fashion Plc, John David Sports Fashion (Ireland) Limited, Spodis SA, Champion Sports Ireland, JD Sprinter Holdings 2010 SL, JD Sports Fashion BV, JD Sports Fashion Germany GmbH, JD Sports Fashion SRL, Duffer of St George Limited, Topgrade Sportswear Limited, Kooga Rugby Limited, Focus Brands Limited, Kukri Sports Limited, Source Lab Limited, R.D. Scott Limited, Tessuti Group Limited, Nicholas Deakins Limited, Cloggs Online Limited, Ark Fashion Limited and Mainline Menswear Limited. The Outdoor segment consists of Blacks Outdoor Retail Ltd. Tiso Group Ltd and ActivInstinct Limited. The company was founded by John Carruthers Wardle and David Martin Makin in 1981 and is headquartered in Bury, the United Kingdom.
Northland Power stock logo

#2 - Northland Power

OTCMKTS:NPIFF
Stock Price: $22.02 (+$0.21)
PE Ratio: -69.66
Average Trading Volume: 9,699 shares
Dividend Yield: 7.24%
Consensus Rating: Buy (3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $50.75 (130.5% Upside)
Northland Power, Inc. engages in the development, building, owning, and management of wind facilities. It operates through the following segments: Offshore Wind, Efficient Natural Gas, Onshore Renewable, Utility, and Other. The Offshore Wind segment consists of Gemini, Nordsee One, and Deutsche Bucht projects. The Onshore Renewables segment consists of Solar, Grand Bend, Jardin, Mont Louis, Cochrane, McLeans, and La Lucha projects. The Efficient Natural Gas includes North Battleford, Iroquois Falls, Kirkland Lake, Kingston, Thorold, and Spy Hill projects. The Utility segment operates Empresa de Energía de Boyacá S.A E.S.P. (EBSA) project. The Other segment focuses on investment income and administration activities. The company was founded by James C. Temerty in 1987 and is headquartered in Toronto, Canada.
Everi stock logo

#3 - Everi

NYSE:EVRI
Stock Price: $15.06 (+$0.34)
PE Ratio: 12.45
Market Cap: $1.34 billion
Average Trading Volume: 753,770 shares
P/E Ratio: 12.4
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $26.20 (74.0% Upside)
Everi Holdings, Inc. engages in the provision of technology solutions to the casino, interactive, and gaming industry. It operates through the Games and Financial Technology Solutions (FinTech) segments. The Games segment focuses on leased gaming equipment, sales of gaming equipment, gaming systems, interactive solutions, and ancillary products and services. The FinTech segment provides access to cash at gaming facilities via ATM cash withdrawals, credit card cash access transactions and point of sale debit card cash access transactions, check-related services, fully integrated kiosks and maintenance services, compliance, audit and data software, casino credit data, and reporting services and other ancillary offerings. The company was founded on February 4, 2004 and is headquartered in Las Vegas, NV.
Mirum Pharmaceuticals stock logo

#4 - Mirum Pharmaceuticals

NASDAQ:MIRM
Stock Price: $26.02 (-$0.03)
PE Ratio: -7.13
Market Cap: $989.54 million
Average Trading Volume: 445,099 shares
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $49.00 (88.3% Upside)
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Ocular Therapeutix stock logo

#5 - Ocular Therapeutix

NASDAQ:OCUL
Stock Price: $6.46 (+$0.09)
PE Ratio: -5.43
Market Cap: $500.84 million
Average Trading Volume: 1.30 million shares
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $12.80 (98.1% Upside)
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Dyne Therapeutics stock logo

#6 - Dyne Therapeutics

NASDAQ:DYN
Stock Price: $13.70 (+$0.54)
PE Ratio: -4.11
Market Cap: $798.85 million
Average Trading Volume: 350,810 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $25.83 (88.6% Upside)
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
InflaRx stock logo

#7 - InflaRx

NASDAQ:IFRX
Stock Price: $4.57 (+$0.20)
PE Ratio: -7.37
Market Cap: $204.28 million
Average Trading Volume: 1.65 million shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $14.00 (206.3% Upside)
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Avidity Biosciences stock logo

#8 - Avidity Biosciences

NASDAQ:RNA
Stock Price: $10.82 (+$0.13)
PE Ratio: -3.22
Market Cap: $766.27 million
Average Trading Volume: 1.14 million shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $42.60 (293.7% Upside)
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Skyward Specialty Insurance Group stock logo

#9 - Skyward Specialty Insurance Group

NASDAQ:SKWD
Stock Price: $23.92 (-$0.14)
Market Cap: $900.83 million
Average Trading Volume: 192,245 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $26.67 (11.5% Upside)
Skyward Specialty Insurance Group Inc. is an insurance holding company, engages in underwriting commercial property and casualty insurance coverages principally in the United States. Skyward Specialty Insurance Group Inc. is based in Houston, Texas.
89bio stock logo

#10 - 89bio

NASDAQ:ETNB
Stock Price: $16.99 (+$0.08)
PE Ratio: -6.02
Market Cap: $1.24 billion
Average Trading Volume: 1.80 million shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $34.00 (100.1% Upside)
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
CymaBay Therapeutics stock logo

#11 - CymaBay Therapeutics

NASDAQ:CBAY
Stock Price: $9.11 (+$0.06)
PE Ratio: -7.72
Market Cap: $888.32 million
Average Trading Volume: 1.65 million shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $14.57 (59.9% Upside)
CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.
Graphic Packaging stock logo

#12 - Graphic Packaging

NYSE:GPK
Stock Price: $25.76 (+$0.13)
PE Ratio: 12.88
Market Cap: $7.91 billion
Average Trading Volume: 3.09 million shares
P/E Ratio: 12.9
Dividend Yield: 1.56%
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $28.78 (11.7% Upside)
Graphic Packaging Holding Co. engages in the provision of paper-based packaging solutions for a variety of products to food, beverage and other consumer products companies. It operates through the following business segments: Paperboard Mills, Americas Paperboard Packaging, Europe Paperboard Packaging, and Corporate and Other. The Paperboard Mills segment includes the eight North American paperboard mills which produce coated unbleached kraft paperboard and coated-recycled paperboard. The Americas Paperboard Packaging segment consists of paperboard folding cartons sold to consumer-packaged goods companies serving the food, beverage and consumer product markets in the Americas. The Europe Paperboard Packaging segment provides paperboard folding cartons sold to consumer-packaged goods companies serving the food, beverage and consumer product markets in Europe. The Corporate and Other segment deals with the Pacific Rim and Australia operating segments and unallocated corporate and one-time costs. The company was founded on December 28, 1992, and is headquartered in Atlanta, GA.
Energy Transfer stock logo

#13 - Energy Transfer

NYSE:ET
Stock Price: $12.76 (+$0.04)
PE Ratio: 9.52
Market Cap: $40.08 billion
Average Trading Volume: 12.10 million shares
P/E Ratio: 9.5
Dividend Yield: 9.67%
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $16.43 (28.8% Upside)
Energy Transfer LP provides natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acq
Atlas Energy Solutions stock logo

#14 - Atlas Energy Solutions

NYSE:AESI
Stock Price: $17.72 (+$0.18)
Market Cap: $1.77 billion
Average Trading Volume: 475,214 shares
Dividend Yield: 0.86%
Consensus Rating: Buy (9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $24.44 (37.9% Upside)
Atlas Energy Solutions Inc. is a provider of proppant and logistics services to customers engaged in the oil and natural gas industry principally within the Permian Basin of West Texas and New Mexico. Atlas Energy Solutions Inc. is based in AUSTIN, Texas.
Xencor stock logo

#15 - Xencor

NASDAQ:XNCR
Stock Price: $27.45 (+$1.40)
PE Ratio: -11.73
Market Cap: $1.66 billion
Average Trading Volume: 349,884 shares
Consensus Rating: Buy (12 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $45.00 (63.9% Upside)
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Imperial Brands stock logo

#16 - Imperial Brands

OTCMKTS:IMBBY
Stock Price: $22.31 (+$0.14)
Market Cap: $20.58 billion
Average Trading Volume: 144,342 shares
Dividend Yield: 10.85%
Consensus Rating: Buy (3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2,425.00 (10,769.6% Upside)
Imperial Brands Plc is a holding company which engages in the manufacture and sale of cigarettes, tobaccos, cigars, rolling papers, and tubes. It operates through the Tobacco and Next Generation Product (NGP), and Distribution segments. The Tobacco and NGP segment manufactures, markets, and sells Tobacco and NGP, and its related products. The Distribution segment is involved in the distribution of tobacco and NGP products for product manufacturers, including Imperial Brands. The company was founded in 1636 and is headquartered in Bristol, the United Kingdom.
ORIC Pharmaceuticals stock logo

#17 - ORIC Pharmaceuticals

NASDAQ:ORIC
Stock Price: $4.96
PE Ratio: -2.26
Market Cap: $223.65 million
Average Trading Volume: 214,551 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $13.20 (166.1% Upside)
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
ADENTRA stock logo

#18 - ADENTRA

OTCMKTS:HDIUF
Stock Price: $21.07 (+$1.05)
PE Ratio: 25.90
Average Trading Volume: 1,323 shares
P/E Ratio: 25.9
Dividend Yield: 1.51%
Consensus Rating: Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $48.67 (131.0% Upside)
ADENTRA, Inc. engages in the sourcing and distribution of architectural grade building products to the residential and commercial construction sectors. The firm's products include hardwood lumber, decorative surfaces and composite panels. It operates through the following geographical segments: Canada and United States. The company was founded on April 5, 2011 and is headquartered in Langley, Canada.
MoonLake Immunotherapeutics stock logo

#19 - MoonLake Immunotherapeutics

NASDAQ:MLTX
Stock Price: $27.55 (-$0.54)
PE Ratio: -23.96
Market Cap: $1.45 billion
Average Trading Volume: 250,957 shares
Consensus Rating: Buy (11 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $25.29 (-8.2% Upside)
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
Deutsche Telekom stock logo

#20 - Deutsche Telekom

OTCMKTS:DTEGY
Stock Price: $23.58 (+$0.16)
PE Ratio: 5.67
Market Cap: $112.27 billion
Average Trading Volume: 216,008 shares
P/E Ratio: 5.7
Dividend Yield: 3.15%
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $27.58 (17.0% Upside)
Deutsche Telekom AG engages in the provision of telecommunications and information technology services. It operates through the following segments: Germany, United States, Europe, Systems Solutions, Group Development, and Group Headquarters and Group Services. The Germany segment comprises fixed-network and mobile activities for consumers and business customers in Germany, as well as telecommunications services for carriers. The United States segment combines mobile activities in the U.S. market. The Europe segment includes fixed-network and mobile operations of the national companies in Greece, Romania, Hungary, Poland, the Czech Republic, Croatia, Slovakia, Austria, North Macedonia, and Montenegro. The Systems Solutions segment offers integrated products and solutions to business customers. The Group Development segment manages entities, subsidiaries, and equity investments. The Group Headquarters and Group Services segment pertains to other Group units and focuses on technology and innovation. The company was founded on January 1, 1995 and is headquartered in Bonn, Germany.
EngageSmart stock logo

#21 - EngageSmart

NYSE:ESMT
Stock Price: $17.97 (+$0.17)
PE Ratio: 138.24
Market Cap: $3.00 billion
Average Trading Volume: 498,982 shares
P/E Ratio: 138.2
Consensus Rating: Buy (6 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $25.88 (44.0% Upside)
EngageSmart, Inc. provides Software-as-a-Service based customer engagement software and integrated payment solutions. It operates through two segments, Enterprise Solutions and SMB (small and medium sized business) Solutions. The company offers SimplePractice, an end-to-end practice management and electronic health record platform for health and wellness professionals to manage their practices; and InvoiceCloud, an electronic bill presentment and payment solution that helps government, utility, and financial services customers to digitize billing, client communications, and collections. It also provides HealthPay24, a patient engagement and payment platform that helps health systems, physician groups, dental practices, and medical billers to drive patient self-pay collections; and DonorDrive, a fundraising software platform that helps non-profits, healthcare organizations, and higher education institutions produce virtual events, launch branded donation campaigns, and create peer-to-peer fundraising experiences. The company was formerly known as EngageSmart, LLC. and changed its name to EngageSmart, Inc. in June 2021. EngageSmart, Inc. was incorporated in 2018 and is headquartered in Braintree, Massachusetts.
Spin Master stock logo

#22 - Spin Master

OTCMKTS:SNMSF
Stock Price: $26.60 (+$0.11)
Average Trading Volume: 4,326 shares
Consensus Rating: Buy (3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $49.44 (85.9% Upside)
Spin Master Corp. is an entertainment company, which engages in the design, manufacture, and marketing of toy products. It operates through the following segments: Toys, Entertainment, Digital Games, and Corporate and Other. The Toy segment is involved in the creation, design, manufacturing, licensing, and marketing of consumer products. The Entertainment segment includes creation, development, production, and distribution of multi-platform content for children and families. The Digital Games segment develops, markets, and delivers digital applications, which are distributed via third-party platform providers and monetized through subscriptions or in-app purchases. The Corporate and Other segment refers to the corporate costs, foreign exchange, and merger and acquisition-related costs. The company was founded by Ronnen Harary, Anton Russel Rabie, and Ben Varadi in 1994 and is headquartered in Toronto, Canada.
The Liberty SiriusXM Group stock logo

#23 - The Liberty SiriusXM Group

NASDAQ:LSXMA
Stock Price: $28.16 (-$0.53)
PE Ratio: 8.77
Market Cap: $9.20 billion
Average Trading Volume: 1.16 million shares
P/E Ratio: 8.8
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $57.00 (102.4% Upside)
Liberty Media Corp. engages in the operation of media, communications, and entertainment businesses. It operates through the following segments: Sirius XM Holdings, Formula 1. The Sirius XM Holdings segment refers to the complementary audio entertainment businesses, Sirius XM and Pandora. Sirius XM features music, sports, entertainment, comedy, talk, news, traffic, weather channels, and infotainment services. Pandora provides music, comedy, and a podcast streaming discovery platform. The Formula 1 segment focuses on the global motorsports business that holds exclusive commercial rights with respect to the World Championship, an annual, motor race-based competition. The company was founded on March 28, 1991, and is headquartered in Englewood, CO.
IGM Financial stock logo

#24 - IGM Financial

OTCMKTS:IGIFF
Stock Price: $28.95 (-$0.14)
PE Ratio: 9.14
Average Trading Volume: 3,925 shares
P/E Ratio: 9.1
Dividend Yield: 5.62%
Consensus Rating: Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $46.29 (59.9% Upside)
IGM Financial, Inc. operates as a financial services company, which engages in the management and distribution of mutual funds and other managed asset products. It operates through the following segments: Wealth Management, Asset Management, and Strategic Investments & Other. The Wealth Management segment reflects the activities of operating companies that are principally focused on providing financial planning and related services to Canadian households, which includes the activities of IG Wealth Management and Investment Planning Counsel. These firms are retail distribution organizations who serve Canadian households through their securities dealers, mutual fund dealers and other subsidiaries licensed to distribute financial products and services, which also includes the investment management activities of these organizations, including mutual fund management and discretionary portfolio management services. The Asset Management segment reflects the activities of operating companies focused on providing investment management services and represents the operations of Mackenzie Investments. Investment management services are provided to a suite of investment funds that are distribut
DarioHealth stock logo

#25 - DarioHealth

NASDAQ:DRIO
Stock Price: $3.75 (-$0.02)
PE Ratio: -2.60
Market Cap: $98.85 million
Average Trading Volume: 154,219 shares
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $11.40 (204.0% Upside)
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.

More Stock Ideas from MarketBeat

My Account -